Suwon, South Korea

Jae-Myeong Kong

This inventor holds 1 USPTO granted patent. Top assignee: Samjin Pharmaceuticazl Co., Ltd.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae-Myeong Kong. Retrieved from https://idiyas.com/inventor/jae-myeong-kong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Jae-Myeong Kong

Introduction

Jae-Myeong Kong is a notable inventor based in Suweon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on piperazine derivatives. With a focus on enhancing the preparation methods for these compounds, Jae-Myeong plays a critical role in advancing pharmaceutical research and development.

Latest Patents

Jae-Myeong Kong holds one patent titled "Piperazine derivatives and methods for the preparation thereof." This patent showcases his expertise in synthesizing piperazine compounds, which are essential in various medicinal applications.

Career Highlights

Currently, Jae-Myeong is employed at Samjin Pharmaceutical Co., Ltd., where he continues to work on cutting-edge pharmaceutical innovations. His career is marked by a commitment to improving drug development processes and enhancing the efficacy of pharmaceutical products.

Collaborations

Throughout his career, Jae-Myeong has collaborated with esteemed colleagues, including Eui-Hwan Cho and Sun-Gan Chung, who contribute their diverse expertise to advance their shared goals in the pharmaceutical industry. Their teamwork highlights the importance of collaboration in scientific research and innovation.

Conclusion

Jae-Myeong Kong's contributions to the field of pharmaceuticals through his patents and collaborative efforts make him a valuable figure in the industry. His work not only benefits his company, Samjin Pharmaceutical Co., Ltd., but also contributes to the broader landscape of pharmaceutical innovation, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…